Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11891469rdf:typepubmed:Citationlld:pubmed
pubmed-article:11891469lifeskim:mentionsumls-concept:C0011923lld:lifeskim
pubmed-article:11891469lifeskim:mentionsumls-concept:C0023516lld:lifeskim
pubmed-article:11891469lifeskim:mentionsumls-concept:C0038143lld:lifeskim
pubmed-article:11891469lifeskim:mentionsumls-concept:C1112209lld:lifeskim
pubmed-article:11891469lifeskim:mentionsumls-concept:C0009361lld:lifeskim
pubmed-article:11891469pubmed:issue2lld:pubmed
pubmed-article:11891469pubmed:dateCreated2002-3-13lld:pubmed
pubmed-article:11891469pubmed:abstractTextRadiolabelling of leukocytes using labelled phagocytosed technetium-99m (99mTc) colloidal radiopharmaceuticals has been reported as a method for imaging infection. This in vivo study compares the use of leukocytes labelled using 99mTc stannous fluoride colloid with leukocytes labelled using indium-111 (111In) oxinate. A total of 26 patients (10 male, 16 female; mean age 52 years, range 23-88 years) referred for the investigation of possible infection were studied using both leukocyte labelling methods simultaneously. Images were acquired 4h and 24h after re-injection of the labelled cells. The images were evaluated qualitatively by two nuclear medicine physicians. The results show a high degree of concordance between the techniques: 11 of the 28 images showed a focus of leukocyte accumulation with both techniques at 24h, and 13 out of 28 showed a normal appearance at 24h with both methods. In four cases the results were discordant; the 99mTc stannous fluoride colloid labelled leukocytes gave a false positive appearance at 24h in three patients and a false negative in one. In conclusion, colloid labelling of leukocytes offers a sensitive method for the detection of infective foci coupled with the high resolution imaging offered by 99mTc. It has the advantage over other in vitro labelling methods of being a simpler, non-labour-intensive procedure employing whole blood, and its use should be considered by departments that have limited facilities for in vitro leukocyte labelling.lld:pubmed
pubmed-article:11891469pubmed:languageenglld:pubmed
pubmed-article:11891469pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11891469pubmed:citationSubsetIMlld:pubmed
pubmed-article:11891469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11891469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11891469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11891469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11891469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11891469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11891469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11891469pubmed:statusMEDLINElld:pubmed
pubmed-article:11891469pubmed:monthFeblld:pubmed
pubmed-article:11891469pubmed:issn0143-3636lld:pubmed
pubmed-article:11891469pubmed:authorpubmed-author:CoakleyA JAJlld:pubmed
pubmed-article:11891469pubmed:authorpubmed-author:O'DohertyM...lld:pubmed
pubmed-article:11891469pubmed:authorpubmed-author:CarterN JNJlld:pubmed
pubmed-article:11891469pubmed:authorpubmed-author:BarringtonS...lld:pubmed
pubmed-article:11891469pubmed:authorpubmed-author:EustanceC N...lld:pubmed
pubmed-article:11891469pubmed:issnTypePrintlld:pubmed
pubmed-article:11891469pubmed:volume23lld:pubmed
pubmed-article:11891469pubmed:ownerNLMlld:pubmed
pubmed-article:11891469pubmed:authorsCompleteYlld:pubmed
pubmed-article:11891469pubmed:pagination153-60lld:pubmed
pubmed-article:11891469pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:meshHeadingpubmed-meshheading:11891469...lld:pubmed
pubmed-article:11891469pubmed:year2002lld:pubmed
pubmed-article:11891469pubmed:articleTitleImaging of abdominal infection using 99m Tc stannous fluoride colloid labelled leukocytes.lld:pubmed
pubmed-article:11891469pubmed:affiliationEast Kent Hospitals NHS Trust, Kent and Canterbury Hospital, Canterbury, Kent, UK. Nicholas.Carter@phnt.swest.nhs.uklld:pubmed
pubmed-article:11891469pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11891469pubmed:publicationTypeComparative Studylld:pubmed